论文部分内容阅读
目的:观察和评价化疗并用乌体林斯治疗初治肺结核的疗效。方法:将95例初治肺结核患者随机分为化疗加乌体林斯的治疗组(A)组48例和仅用化疗的对照组(B)组47例。结果:疗程结束痰菌阴转率A、B组分别为95％和77.8％;疗程结束病灶全吸加显吸的显效率A、B组分别为91.7％和66％;空洞闭合率A、B组分别为87.5%和60％。结论:乌体林斯能改善肺结核患者的细胞免疫功能,增强化疗效果,加速痰苗阴转,促进病灶吸收和空洞闭合。
OBJECTIVE: To observe and evaluate the efficacy of chemotherapy and Wu-li-linsi in the treatment of newly-diagnosed pulmonary tuberculosis. Methods: Ninety-five newly diagnosed pulmonary tuberculosis patients were randomly divided into chemotherapy group (48 cases in group A) and group B (47 cases in group B). Results: At the end of treatment, sputum negative conversion rate was 95% in group A and 77.8% in group B, respectively. The effective rates of whole absorption and significant suction of the lesions at the end of treatment were 91.7% and 66% respectively. The void closure rates A and B Groups were 87.5% and 60% respectively. CONCLUSION: Ulliphinsi can improve the cellular immune function of patients with pulmonary tuberculosis, enhance the effect of chemotherapy, accelerate the negative conversion of sputum and accelerate the absorption of the lesion and the cavity closure.